Vise Technologies Inc. purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 4,071 shares of the company’s stock, valued at approximately $931,000.
A number of other hedge funds have also recently modified their holdings of MOH. Torren Management LLC bought a new position in Molina Healthcare in the 4th quarter worth $26,000. Physician Wealth Advisors Inc. grew its holdings in Molina Healthcare by 1,250.0% during the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock valued at $29,000 after purchasing an additional 200 shares during the period. Quarry LP bought a new stake in Molina Healthcare during the fourth quarter valued at about $32,000. SJS Investment Consulting Inc. increased its position in Molina Healthcare by 504.9% in the first quarter. SJS Investment Consulting Inc. now owns 248 shares of the company’s stock worth $33,000 after buying an additional 207 shares in the last quarter. Finally, Elevation Wealth Partners LLC increased its position in Molina Healthcare by 118.2% in the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after buying an additional 78 shares in the last quarter. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Price Performance
MOH stock opened at $200.63 on Monday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The company’s fifty day moving average price is $211.25 and its 200-day moving average price is $178.56. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $244.89. The company has a market capitalization of $10.47 billion, a PE ratio of -1,114.55, a price-to-earnings-growth ratio of 28.70 and a beta of 0.75.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on the company. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective on the stock in a research report on Wednesday, April 29th. Royal Bank Of Canada reduced their target price on shares of Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating for the company in a report on Friday, July 24th. JPMorgan Chase & Co. raised their target price on shares of Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a research note on Monday, June 8th. Barclays lowered their price target on shares of Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating on the stock in a report on Friday, July 24th. Finally, Morgan Stanley upped their price target on shares of Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $202.44.
Check Out Our Latest Stock Analysis on MOH
Molina Healthcare Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Read More
- Five stocks we like better than Molina Healthcare
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
